Search Results

There are 5611 results for: content related to: Immunogenicity, Safety, and Efficacy of Abatacept Administered Subcutaneously With or Without Background Methotrexate in Patients With Rheumatoid Arthritis: Results From a Phase III, International, Multicenter, Parallel-Arm, Open-Label Study

  1. Abatacept for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Lara Maxwell and Jasvinder A Singh

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD007277.pub2

  2. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  3. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  4. You have full text access to this OnlineOpen article
    Long-Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years

    Arthritis & Rheumatology

    Volume 67, Issue 10, October 2015, Pages: 2759–2770, Daniel J. Lovell, Nicolino Ruperto, Richard Mouy, Eliana Paz, Nadina Rubio-Pérez, Clovis A. Silva, Carlos Abud-Mendoza, Ruben Burgos-Vargas, Valeria Gerloni, Jose A. Melo-Gomes, Claudia Saad-Magalhaes, J. Chavez-Corrales, Christian Huemer, Alan Kivitz, Francisco J. Blanco, Ivan Foeldvari, Michael Hofer, Hans-Iko Huppertz, Chantal Job Deslandre, Kirsten Minden, Marilynn Punaro, Alan J. Block, Edward H. Giannini, Alberto Martini and for the Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology International Trials Organisation

    Version of Record online : 23 SEP 2015, DOI: 10.1002/art.39234

  5. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  6. Modeling and Simulation of Abatacept Exposure and Interleukin-6 Response in Support of Recommended Doses for Rheumatoid Arthritis

    The Journal of Clinical Pharmacology

    Volume 47, Issue 11, November 2007, Pages: 1408–1420, Dr Amit Roy, Dr Diane R. Mould, Dr Xiao-Feng Wang, Dr Lee Tay, Mr Ralph Raymond and Dr Marc Pfister

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007307573

  7. Abatacept: A Novel Treatment for Moderate-to-Severe Rheumatoid Arthritis

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 12, December 2007, Pages: 1693–1701, Dr. Jennifer Reynolds, Dr. Kam Shojania and Dr. Carlo A. Marra

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.12.1693

  8. You have full text access to this OnlineOpen article
    Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study

    Arthritis & Rheumatism

    Volume 65, Issue 1, January 2013, Pages: 28–38, Michael E. Weinblatt, Michael Schiff, Robert Valente, Désirée van der Heijde, Gustavo Citera, Cathy Zhao, Michael Maldonado and Roy Fleischmann

    Version of Record online : 27 DEC 2012, DOI: 10.1002/art.37711

  9. You have full text access to this OnlineOpen article
    Subcutaneous abatacept versus intravenous abatacept: A phase IIIb noninferiority study in patients with an inadequate response to methotrexate

    Arthritis & Rheumatism

    Volume 63, Issue 10, October 2011, Pages: 2854–2864, M. C. Genovese, A. Covarrubias, G. Leon, E. Mysler, M. Keiserman, R. Valente, P. Nash, J. A. Simon-Campos, W. Porawska, J. Box, C. Legerton III, E. Nasonov, P. Durez, R. Aranda, R. Pappu, I. Delaet, J. Teng and R. Alten

    Version of Record online : 27 SEP 2011, DOI: 10.1002/art.30463

  10. Improving patient outlook in rheumatoid arthritis: Experience with abatacept

    Journal of the American Academy of Nurse Practitioners

    Volume 20, Issue 10, October 2008, Pages: 486–495, Mary Coughlin

    Version of Record online : 16 OCT 2008, DOI: 10.1111/j.1745-7599.2008.00340.x

  11. You have free access to this content
    Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study

    Arthritis & Rheumatism

    Volume 54, Issue 9, September 2006, Pages: 2807–2816, M. Weinblatt, B. Combe, A. Covucci, R. Aranda, J. C. Becker and E. Keystone

    Version of Record online : 31 AUG 2006, DOI: 10.1002/art.22070

  12. You have free access to this content
    Abatacept for lupus nephritis: Alternative definitions of complete response support conflicting conclusions

    Arthritis & Rheumatism

    Volume 64, Issue 11, November 2012, Pages: 3660–3665, David Wofsy, Jan L. Hillson and Betty Diamond

    Version of Record online : 27 OCT 2012, DOI: 10.1002/art.34624

  13. You have free access to this content
    Abatacept, a Novel CD80/86–CD28 T Cell Co-stimulation Modulator, in the Treatment of Rheumatoid Arthritis

    Basic & Clinical Pharmacology & Toxicology

    Volume 104, Issue 4, April 2009, Pages: 276–284, Riku Korhonen and Eeva Moilanen

    Version of Record online : 18 FEB 2009, DOI: 10.1111/j.1742-7843.2009.00375.x

  14. You have free access to this content
    Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis

    Arthritis & Rheumatism

    Volume 62, Issue 6, June 2010, Pages: 1792–1802, Nicolino Ruperto, Daniel J. Lovell, Pierre Quartier, Eliana Paz, Nadina Rubio-Pérez, Clovis A. Silva, Carlos Abud-Mendoza, Ruben Burgos-Vargas, Valeria Gerloni, Jose A. Melo-Gomes, Claudia Saad-Magalhães, J. Chavez-Corrales, Christian Huemer, Alan Kivitz, Francisco J. Blanco, Ivan Foeldvari, Michael Hofer, Gerd Horneff, Hans-Iko Huppertz, Chantal Job-Deslandre, Anna Loy, Kirsten Minden, Marilynn Punaro, Alejandro Flores Nunez, Leonard H. Sigal, Alan J. Block, Marleen Nys, Alberto Martini and Edward H. Giannini

    Version of Record online : 26 FEB 2010, DOI: 10.1002/art.27431

  15. You have free access to this content
    Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents

    Clinical & Experimental Immunology

    Volume 177, Issue 3, September 2014, Pages: 630–640, A. Picchianti Diamanti, M. M. Rosado, M. Scarsella, V. Germano, E. Giorda, S. Cascioli, B. Laganà, R. D'Amelio and R. Carsetti

    Version of Record online : 24 JUL 2014, DOI: 10.1111/cei.12367

  16. You have free access to this content
    Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial

    Arthritis & Rheumatism

    Volume 52, Issue 8, August 2005, Pages: 2263–2271, Joel M. Kremer, Maxime Dougados, Paul Emery, Patrick Durez, Jean Sibilia, William Shergy, Serge Steinfeld, Elizabeth Tindall, Jean-Claude Becker, Tracy Li, Isaac F. Nuamah, Richard Aranda and Larry W. Moreland

    Version of Record online : 28 JUL 2005, DOI: 10.1002/art.21201

  17. Adverse effects of biologics: a network meta-analysis and Cochrane overview

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, George A Wells, Robin Christensen, Elizabeth Tanjong Ghogomu, Lara J Maxwell, John K MacDonald, Graziella Filippini, Nicole Skoetz, Damian K Francis, Luciane C Lopes, Gordon H Guyatt, Jochen Schmitt, Loredana La Mantia, Tobias Weberschock, Juliana F Roos, Hendrik Siebert, Sarah Hershan, Chris Cameron, Michael PT Lunn, Peter Tugwell and Rachelle Buchbinder

    Published Online : 16 FEB 2011, DOI: 10.1002/14651858.CD008794.pub2

  18. You have free access to this content
    Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate

    Arthritis & Rheumatism

    Volume 58, Issue 4, April 2008, Pages: 953–963, Joel M. Kremer, Harry K. Genant, Larry W. Moreland, Anthony S. Russell, Paul Emery, Carlos Abud-Mendoza, Jacek Szechiński, Tracy Li, Julie Teng, Jean-Claude Becker and René Westhovens

    Version of Record online : 27 MAR 2008, DOI: 10.1002/art.23397

  19. The clinical utility of inhibiting CD28-mediated costimulation

    Immunological Reviews

    Volume 229, Issue 1, May 2009, Pages: 307–321, Peter S. Linsley and Steven G. Nadler

    Version of Record online : 21 APR 2009, DOI: 10.1111/j.1600-065X.2009.00780.x

  20. Systematic review of the effectiveness of biological therapy for active moderate to severe ulcerative colitis

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 6, June 2014, Pages: 1159–1170, Paweł Kawalec, Alicja Mikrut and Sylwia Łopuch

    Version of Record online : 15 MAY 2014, DOI: 10.1111/jgh.12563